TNXP
Tonix Pharmaceuticals Holding Corp
8.90$
-3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | +7.9% | -100.0% | – | -100.0% | – | -5.3% | -34.3% | -11.0% | +27.8% | -8.5% | -5.9% | -17.7% | +64.7% | +63.8% | +27.6% | +96.9% | – | |
| – | -100.0% | – | -5.3% | +21.0% | +264.9% | -67.2% | -12.1% | -9.8% | -100.0% | – | -6.2% | +33.6% | – | – | +94.5% | -15.5% | – | – | +13.6% | -21.3% | -99.9% | +133.3% | +61.9% | +147.1% | +231.7% | +6.8% | +3,147.7% | -91.8% | -0.3% | -29.9% | +102.8% | -53.8% | -23.9% | -20.3% | +247.0% | -58.2% | +13.1% | +38.0% | -67.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -811.6% | – | – | – | – | – | +6.3% | -108.8% | – | -187.9% | – | -12.6% | -41.8% | -241.0% | – | +10.4% | +6.2% | -185.7% | – | +99.9% | +23.4% | +170.6% | – | |
| – | -10.7% | -38.6% | -6.3% | +39.3% | -7.0% | +42.3% | -21.3% | -19.7% | +54.9% | -23.0% | -8.8% | +42.1% | +12.6% | -17.8% | +126.1% | -16.6% | +37.3% | +26.7% | +18.3% | -27.9% | +70.4% | -17.4% | -10.0% | +33.9% | +11.1% | +7.4% | -17.1% | -4.2% | -18.7% | -24.9% | -24.6% | -6.0% | -9.0% | -10.4% | +45.5% | -14.1% | +82.4% | +7.5% | +6.6% | – | |
| – | +22.7% | -20.3% | -3.9% | -4.4% | -0.9% | -4.8% | +14.2% | +9.7% | +13.9% | -7.4% | -2.0% | +20.7% | +7.2% | -13.9% | +38.2% | -12.0% | +54.6% | +9.8% | +0.4% | +0.4% | +31.7% | +11.6% | -15.7% | +9.4% | +9.0% | -8.2% | -4.9% | +24.0% | +33.4% | -19.9% | -19.4% | +2.7% | -55.9% | +197.2% | +60.4% | +58.6% | +2.4% | +8.8% | +25.6% | – | |
| – | -1.3% | -32.2% | -5.3% | +21.0% | -5.0% | +26.1% | -12.1% | -9.8% | +38.1% | -17.7% | -6.2% | +33.6% | +10.7% | -16.5% | +94.5% | -15.5% | +41.9% | +21.8% | +13.6% | -21.3% | +59.0% | -10.3% | -11.7% | +26.8% | +10.6% | +3.6% | -14.5% | +2.6% | +4.5% | -28.7% | -22.4% | -2.2% | +42.0% | -26.5% | +54.1% | +29.5% | +49.0% | -11.2% | +19.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +931.6% | +211.2% | +35.2% | +117.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -131.9% | – | -104.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.